MDCC Molecular Devices (MM)

Molecular Devices to Present at May Conferences SUNNYVALE, Calif., May 9 /PRNewswire-FirstCall/ -- Molecular Devices Corporation (NASDAQ:MDCC), a leader in innovative solutions for drug discovery and life sciences research, today announced that management will present at two conferences in May 2005. On Thursday, May 12, at 1:25 p.m. CDT, CEO and President, Joseph D. Keegan, Ph.D. will present at the Baird 2005 Growth Stock Conference in Chicago. On Thursday, May 19, at 2:00 p.m. PDT, CEO and President, Joseph D. Keegan, Ph.D. will present at the Banc of America Securities Health Care Conference 2005 in Las Vegas. A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Molecular Devices Corporation website, http://www.moleculardevices.com/. A webcast replay for each conference will be accessible at the same website location approximately three hours after the presentation and will remain available for 5 days from the date of presentation. Molecular Devices Corporation is a leading supplier of high-performance bioanalytical measurement systems that accelerate and improve drug discovery and other life sciences research. The Company's systems and consumables enable pharmaceutical and biotechnology companies to leverage advances in genomics, proteomics and parallel chemistry to facilitate the high-throughput and cost-effective identification and evaluation of drug candidates. The Company's solutions are based on its advanced core technologies that integrate its expertise in engineering, molecular and cell biology and chemistry. Molecular Devices enables its customers to improve research productivity and effectiveness, which ultimately accelerates the complex process of discovering and developing new drugs. DATASOURCE: Molecular Devices Corporation CONTACT: Tim Harkness of Molecular Devices Corporation, +1-408-747-3533 Web site: http://www.moleculardevices.com/

Copyright